SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma

Aurobindo Pharma

BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 21, 11:13
672.00
2.45 (0.37%)
VOLUME 40,584
LIVE
NSE
Feb 21, 11:14
671.50
2.1 (0.31%)
VOLUME 385,799
News on Aurobindo Pharma
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Aurobindo Pharma; target of Rs 800: Axis Direct

5.03 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 800 in its research report dated February...

Buy Aurobindo Pharma; target of Rs 1110: Centrum

12.54 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1110 in its research report dated February 10...

Here is why SP Tulsian is bullish on Petronet LNG 

7.40 pm | 17 Feb 2017 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com, explains why he is bullish on Petronet LNG. He also discusses key pharma sector likes Cadila Healthcare, Divis Laboratori...

Dilip Bhat positive on pharma sector 

5.06 pm | 17 Feb 2017 |  Source: CNBC-TV18

Dilip Bhat of Prabhudas Lilladher is positive on the pharma sector largely because of the growth factor and because of the profitabilities....

Vedanta may test Rs 270-272, says Hemant Thukral 

12.04 pm | 17 Feb 2017 |  Source: CNBC-TV18

Hemant Thukral, National Head-Derivative Desk at Aditya Birla Money is of the view that Vedanta may test Rs 270-272....

Nifty largely stock-specific; may remain range-bound: Pro 

3.46 pm | 16 Feb 2017 |  Source: Moneycontrol.com

There seems to be no big money in the market, says Ashwani Gujral of ashwanigujral.com. Nifty will continue to remain choppy till it crosses the 8,820...

Buy Aurobindo Pharma; target of Rs 917: Khambatta Securities

4.11 pm | 15 Feb 2017 |  Source: Moneycontrol.com

Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 917 in its research report dated...

Buy HDFC Bank, sell Aurobindo Pharma: Sudarshan Sukhani 

3.48 pm | 15 Feb 2017 |  Source: CNBC-TV18

According to Sudarshan Sukhani of s2analytics.com, one can buy HDFC Bank and feels that one can sell Aurobindo Pharma....

Dr Reddy's, Aurobindo recall drugs from US market

2.40 pm | 15 Feb 2017 |  Source: PTI

According to a notification issued by the US Food and Drug Authority, Dr Reddy's is recalling Olanzapine tablets USP of 2.5 mg while Aurobindo is reca...

Buy Aurobindo Pharma; target of Rs 1050: Motilal Oswal

6.33 pm | 14 Feb 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1050 in its research report dated Febru...

Buy Aurobindo Pharma; target of Rs 965: ICICI Direct

5.02 pm | 13 Feb 2017 |  Source: Moneycontrol.com

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 965 in its research report dated Februar...

Buy Hexaware, Elgi Equipments; sell Auro Pharma: Mitessh Thakkar 

9.50 am | 13 Feb 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com suggests buying Hexaware Technologies, Elgi Equipments and McDowell Holdings and advises selling Aurobindo Pharma...

Bull's Eye: Buy United Spirits, HCL Tech; sell Hind Zinc 

7.46 am | 13 Feb 2017 |  Source: CNBC-TV18

Ashish Kyal of Waves Strategy Advisors is of the view that one may buy United Spirits with a target of Rs 2510....

Aurobindo sees R&D costs to double as it gets into biosimilars

10.16 am | 11 Feb 2017 |  Source: Moneycontrol.com

The company on Friday said it plans to spend about USD 80 million in next two years as it prepares to take the lead biosimilar molecule bevacizumab in...

Aurobindo Pharma eyes US plant amid Trump push on jobs

3.41 pm | 10 Feb 2017 |  Source: Reuters

Trump urged US drug industry executives in a meeting last month to make more drugs locally, and lower drug prices. He has also proposed to impose a pe...

Six in Sixty: Stocks you should keep on your radar 

2.56 pm | 10 Feb 2017 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists six stocks that you should focus on – State Bank of India, Bank of Baroda, Mahindra and Mahindra, Bosch, Grasim, Tech M...

Top buzzing midcap stocks to trade on February 10 

1.28 pm | 10 Feb 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Max Ventures, Sail, Triveni Engineering, Aurobindo Pharma, C...

Pharma bottoming out but invest selectively: Emkay Global 

10.49 am | 10 Feb 2017 |  Source: CNBC-TV18

Speaking to CNBC-TV18, Krishna Kumar Karwa, MD and CEO at Emkay Global Financial Services, said pharma and IT could give relatively better returns in ...

Invest in private sector banks for long-term, says Dipan Mehta 

9.54 am | 10 Feb 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Dipan Mehta, Member of BSE & NSE shared his readings and outlook on specific stocks and sector....

Stocks in news: SBI, Aurobindo, Lupin, Bata, SAIL, Triveni Engg 

8.00 am | 10 Feb 2017 |  Source: CNBC-TV18

SBI | Bank of Baroda | Aurobindo Pharma | Lupin | Tata Steel | Pricol | Power Grid | Bata | Cairn India | SAIL | JK Tyre | Torrent Power | Triveni Eng...

1 2 3 4 5 6 7 8
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.